IL-9

IL-9 詳細

英語名Interleukin-9市販薬剤の数0
治験薬の数1ターゲットの別称Homolog Of Mouse T Cell And Mast Cell Growth Factor 40,P40 T-Cell And Mast Cell Growth Factor,Cytokine P40,P40 Cytokine,IL-9,HP40,P40,IL9,Interleukin-9,T-cell growth factor P40,Interleukin 9
研究&開発段階Phase 2 Clinical
英語名Interleukin-9
ターゲットの別称Homolog Of Mouse T Cell And Mast Cell Growth Factor 40,P40 T-Cell And Mast Cell Growth Factor,Cytokine P40,P40 Cytokine,IL-9,HP40,P40,IL9,Interleukin-9,T-cell growth factor P40,Interleukin 9
市販薬剤の数0
治験薬の数1
研究&開発段階Phase 2 Clinical

IL-9 製品リスト

  • 属性

    Protein (4)Kits (1)

  • 製品ライブラリ

    オンライン (5)

  • Human (4)Mouse (1)

  • タグ

    His Tag (2)Tag Free (1)His Tag & Avi Tag (1)- (1)

  • マーカー

    Unconjugated (3)Biotin-labeled (1)- (1)

IL-9バックグランド

Interleukin-9 (IL-9) is expressed primarily by activated T cells. The growth factor and anti apoptotic activities of IL-9 on multiple transformed cells suggest a potential role for the cytokine in tumourigenesis. IL-9 has also been proposed as a candidate gene for asthma IL-9 is a Th2-derived cyto kine that has been reported to regulate T and B cell function. IL-9was first isolated as a factor capable of sustaining the long-termgrowth of murine T cell clones, but has since been demon strated to have in vitro activities on mast cells, erythroid pro genitors, and B cell Ig expression.

IL-9分子の別称

Interleukin-9,IL-9,Cytokine P40

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
EQ-101EQ101; EQ-101; BNZ132-1-40; BNZ-1; BNZ132-1; BNZ-01Phase 2 ClinicalBioniz Therapeutics IncAlopecia; Alopecia Areata; Leukemia, Large Granular Lymphocytic; Lymphoma, T-Cell, Cutaneous
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8